PET Imaging of the P2X7 Ion Channel with a Novel Tracer [18F]JNJ-64413739 in a Rat Model of Neuroinflammation

• Published in: Molecular imaging and biology 2019-10, Vol.21 (5), p.871-878
• Main Authors: Berdyyeva, Tamara, Xia, Chunfang, Taylor, Natalie, He, Yingbo, Chen, Gang, Huang, Chaofeng, Zhang, Wei, Kolb, Hartmuth, Letavic, Michael, Bhattacharya, Anindya, Szardenings, Anna Katrin
• Format: Article
• Language: English
• Subjects: Adenosine triphosphate; Animals; ATP; Autoradiography; Biomarkers; Biomarkers - metabolism; Brain; Brain - diagnostic imaging; Brain - pathology; Cerebellum; Disease Models, Animal; Fluorine isotopes; Imaging; In vivo methods and tests; Inflammation; Inflammation - diagnostic imaging; Inflammation - pathology; Ion channels; Lipopolysaccharides; Medical imaging; Medicine; Medicine & Public Health; Neuroimaging; Peptides - chemistry; Peptides - pharmacokinetics; Pilot Projects; Polymerase chain reaction; Positron emission; Positron emission tomography; Positron Emission Tomography Computed Tomography; Pyridines - chemistry; Radiology; Radiopharmaceuticals - chemistry; Rats; Receptors; Receptors, Purinergic P2X7 - metabolism; Research Article; Rodents; Tomography; Triazoles - chemistry
• ISSN: 1536-1632; 1860-2002
• DOI: 10.1007/s11307-018-01313-2

Purpose The P2X7 receptor, an adenosine triphosphate (ATP)-gated purinoreceptor, has emerged as one of the key players in neuroinflammatory processes. Therefore, developing a positron emission tomography (PET) tracer for imaging of P2X7 receptors in vivo presents a promising approach to diagnose, monitor, and study neuroinflammation in a variety of brain disorders. To fulfill the goal of developing a P2X7 PET ligand as a biomarker of neuroinflammation, [ 18 F]JNJ-64413739 has been recently disclosed. Procedures We evaluated [ 18 F]JNJ-64413739 in a rat model of neuroinflammation induced by an intracerebral injection of lipopolysaccharide (LPS). In vivo brain uptake was determined by PET imaging. Upregulation of neuroinflammatory biomarkers was determined by quantitative polymerase chain reaction (qPCR). Distribution of the tracer in the brain was determined by ex vivo autoradiography (ARG). The specificity of [ 18 F]JNJ-64413739 was confirmed by performing blocking experiments with the P2X7 antagonist JNJ-54175446. Results Brain regions of rats injected with LPS had a significantly increased uptake (34 % ± 3 % s.e.m., p  = 0.036, t test, standardized uptake value measured over the entire scanning period) of [ 18 F]JNJ-64413739 relative to the corresponding brain regions of control animals injected with phosphate-buffered saline (PBS). The uptake in the contralateral regions and cerebellum was not significantly different between the groups of animals. The increase in uptake of [ 18 F]JNJ-64413739 at the LPS-injected site observed by PET imaging was concordant with ex vivo ARG, upregulation of neuroinflammatory biomarkers, and elevated P2X7 expression levels. Conclusions While further work is needed to study [ 18 F]JNJ-64413739 in other types of neuroinflammation, the current results favorably characterize [ 18 F]JNJ-64413739 as a potential PET tracer of central neuroinflammation.